Seeking Alpha

DUSA
DUSA Pharmaceuticals, Inc.

5/27/2012, 7:52 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
DUSA Market Currents more »
DUSA in Focus more »
DUSA Latest Transcript more »
Currently, there are no transcripts for DUSA.
DUSA Cramer more »
Currently, there are no Cramer articles on DUSA.
DUSA Instablog posts more »
  • DUSA Pharmaceuticals Inc. (DUSA) Posts 27% Hike in Q1 Earnings
    Mon, May 9, 2011 • QualityStocks • Comment!
  • DUSA Pharmaceuticals (DUSA) Posts Higher Earnings, Wider Net Loss
    Fri, May 6, 2011 • QualityStocks • Comment!
Write a post on DUSA
DUSA StockTalks
DUSA vs. ETF Alternatives
Company Description

DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan®... More